Opthea to Host Investor Days in New York and Australia
January 08, 2025 07:00 ET
|
Opthea Limited
Updates on commercial insights and readiness plans for sozinibercept in wet AMD Opthea management to present in New York City on Tuesday, January 28 at 1:30 PM ET In-person events in Sydney on...
Opthea Announces Publication in Diabetic Macular Edema
January 07, 2025 07:00 ET
|
Opthea Limited
Phase 1b clinical data underpins sozinibercept’s potential as a novel, first-in-class VEGF-C/D ‘trap’ to improve visual and anatomic outcomes in DME Published in peer-reviewed journal Translational...
Opthea to Present at 43rd Annual J.P. Morgan Healthcare Conference
December 19, 2024 07:00 ET
|
Opthea Limited
Business update to include masked Phase 3 patient demographics and baseline characteristics Presentation on Wednesday, January 15, 2025, 5:15 PM PT in San Francisco, California MELBOURNE,...
Opthea’s Wet AMD Program to be Featured at FLORetina 2024
November 26, 2024 07:00 ET
|
Opthea Limited
MELBOURNE, Australia, and Princeton, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ:OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel...
Opthea to Participate in Citi 2024 Global Healthcare Conference
November 25, 2024 07:00 ET
|
Opthea Limited
MELBOURNE, Australia and PRINCETON, N.J., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ:OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel...
Opthea Appoints Kathy Connell to Board of Directors
November 15, 2024 07:00 ET
|
Opthea Limited
Ms. Connell is a commercial executive with business development expertise Appointment takes place as Opthea prepares for Phase 3 wet AMD topline data in 2025 MELBOURNE, Australia, and PRINCETON,...
Opthea’s Wet AMD Program Featured at Ophthalmology Events
November 12, 2024 07:00 ET
|
Opthea Limited
17 Congress of the Asia-Pacific Vitreo-Retina Society, November 22 - 24, 2024 Ophthalmology Innovation Summit XIV, November 23, 2024 MELBOURNE, Australia, and PRINCETON, N.J., Nov. 12, 2024 (GLOBE...
Opthea to Participate in November Investor Conferences
November 04, 2024 07:00 ET
|
Opthea Limited
Virtual Bell Potter Healthcare Conference, November 18, 2024 Jefferies London Healthcare Conference, November 19, 2024 MELBOURNE, Australia and PRINCETON, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) --...
Opthea Files Notice of Annual General Meeting
October 16, 2024 07:00 ET
|
Opthea Limited
Megan Baldwin, PhD, MAICD, to retire from the Board and has chosen not to stand for re-election As Founder and Chief Innovation Officer, Dr. Baldwin will continue focusing on advancing Opthea’s...
Opthea Wet AMD Program to be Presented at Innovate Retina
October 10, 2024 07:30 ET
|
Opthea Limited
MELBOURNE, Australia, and Princeton, N.J., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel...